APH.L
Price:
$46.7
Market Cap:
$252.44M
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-11-22
Stock Exchange
LSE
Ticker
APH.L
According to Alliance Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is -7.78. This represents a change of -285.56% compared to the average of 4.19 of the last 4 quarters.
The mean historical PE Ratio of Alliance Pharma plc over the last ten years is 51.61. The current -7.78 PE Ratio has changed -1607.35% with respect to the historical average. Over the past ten years (40 quarters), APH.L's PE Ratio was at its highest in in the June 2018 quarter at 27.20. The PE Ratio was at its lowest in in the December 2021 quarter at -158.95.
Average
51.61
Median
14.90
Minimum
-6.60
Maximum
305.47
Discovering the peaks and valleys of Alliance Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 283.89%
Maximum Annual PE Ratio = 305.47
Minimum Annual Increase = -102.16%
Minimum Annual PE Ratio = -6.60
Year | PE Ratio | Change |
---|---|---|
2023 | -6.60 | -102.16% |
2022 | 305.47 | 283.89% |
2021 | 79.57 | 37.30% |
2020 | 57.96 | 231.01% |
2019 | 17.51 | -3.52% |
2018 | 18.15 | 64.28% |
2017 | 11.05 | -10.14% |
2016 | 12.29 | 33.05% |
2015 | 9.24 | -19.64% |
2014 | 11.50 | 2.68% |
The current PE Ratio of Alliance Pharma plc (APH.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
126.15
5-year avg
90.78
10-year avg
51.61
Alliance Pharma plc’s PE Ratio is less than Advanced Medical Solutions Group plc (40.50), less than iomart Group plc (16.82), less than dotdigital Group Plc (26.30), less than AB Dynamics plc (33.24), greater than GB Group plc (-17.47),
Company | PE Ratio | Market cap |
---|---|---|
40.50 | $450.99M | |
16.82 | $108.90M | |
26.30 | $291.20M | |
33.24 | $453.35M | |
-17.47 | $848.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alliance Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alliance Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alliance Pharma plc's PE Ratio?
How is the PE Ratio calculated for Alliance Pharma plc (APH.L)?
What is the highest PE Ratio for Alliance Pharma plc (APH.L)?
What is the 3-year average PE Ratio for Alliance Pharma plc (APH.L)?
What is the 5-year average PE Ratio for Alliance Pharma plc (APH.L)?
How does the current PE Ratio for Alliance Pharma plc (APH.L) compare to its historical average?